<?xml version="1.0" encoding="UTF-8"?>
<Label drug="visionblue" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    Adverse Reactions

  Adverse reactions reported following use of VisionBlueTM include discoloration of high water content hydrogen intraocular lenses (see Contraindications) and inadvertent staining of the posterior lens capsule and vitreous face.  Staining of the posterior lens capsule or staining of the vitreous face is generally self limited, lasting up to one week.
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
